Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>8-iso Prostaglandin F2α

8-iso Prostaglandin F2α (Synonyms: iPF2α-III, 8-iso-15(S)-Prostaglandin F2α, 8-Isoprostane, 8-epi PGF2α, 15-F2t-Isoprostane)

Catalog No.GC18515

8-iso PGF2α is an isoprostane produced by the non-enzymatic peroxidation of arachidonic acid in membrane phospholipids.

Products are for research use only. Not for human use. We do not sell to patients.

8-iso Prostaglandin F2α Chemical Structure

Cas No.: 27415-26-5

Size Price Stock Qty
1mg
$231.00
In stock
5mg
$977.00
In stock
10mg
$1,726.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
8-iso PGF2α is an isoprostane produced by the non-enzymatic peroxidation of arachidonic acid in membrane phospholipids. It is present in human plasma in two distinct forms - esterified in phospholipids and as the free acid. The ratio of these two forms is approximately 2:1, with a total plasma 8-iso PGF2α level of about 150 pg/ml in normal volunteers. In normal human urine, 8-iso PGF2α levels are about 180-200 pg/mg of creatinine. 8-iso PGF2α is a weak TP receptor agonist in vascular smooth muscle. Conversely, 8-iso PGF2α inhibits platelet aggregation induced by U-46619 (10-6 M) and I-BOP (3 x 10-7 M) with IC50 values of 1.6 x 10-6 M and 1.8 x 10-6 M, respectively.

Reviews

Review for 8-iso Prostaglandin F2α

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 8-iso Prostaglandin F2α

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.